Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 153

Similar articles for PubMed (Select 22239234)

1.

Associations between demographic variables and multiple measles-specific innate and cell-mediated immune responses after measles vaccination.

Umlauf BJ, Haralambieva IH, Ovsyannikova IG, Kennedy RB, Pankratz VS, Jacobson RM, Poland GA.

Viral Immunol. 2012 Feb;25(1):29-36. doi: 10.1089/vim.2011.0051. Epub 2012 Jan 12.

2.

Independence of measles-specific humoral and cellular immune responses to vaccination.

Jacobson RM, Ovsyannikova IG, Vierkant RA, Pankratz VS, Poland GA.

Hum Immunol. 2012 May;73(5):474-9. doi: 10.1016/j.humimm.2012.02.016. Epub 2012 Mar 3.

3.

Th1 and Th2 cytokine responses after measles antigen stimulation in vitro in bone marrow transplant patients: response to measles vaccination.

Pauksen K, Sjölin J, Linde A, Alm G, Andersson B, Lönnerholm G, Ljungman P.

Bone Marrow Transplant. 1997 Aug;20(4):317-23.

4.

The association of CD46, SLAM and CD209 cellular receptor gene SNPs with variations in measles vaccine-induced immune responses: a replication study and examination of novel polymorphisms.

Ovsyannikova IG, Haralambieva IH, Vierkant RA, O'Byrne MM, Jacobson RM, Poland GA.

Hum Hered. 2011;72(3):206-23. doi: 10.1159/000331585. Epub 2011 Nov 11.

5.

Frequency of measles virus-specific CD4+ and CD8+ T cells in subjects seronegative or highly seropositive for measles vaccine.

Ovsyannikova IG, Dhiman N, Jacobson RM, Vierkant RA, Poland GA.

Clin Diagn Lab Immunol. 2003 May;10(3):411-6.

6.

Correlations among measles virus-specific antibody, lymphoproliferation and Th1/Th2 cytokine responses following measles-mumps-rubella-II (MMR-II) vaccination.

Dhiman N, Ovsyannikova IG, Ryan JE, Jacobson RM, Vierkant RA, Pankratz VS, Jacobsen SJ, Poland GA.

Clin Exp Immunol. 2005 Dec;142(3):498-504.

7.

Associations between single nucleotide polymorphisms and haplotypes in cytokine and cytokine receptor genes and immunity to measles vaccination.

Haralambieva IH, Ovsyannikova IG, Kennedy RB, Vierkant RA, Pankratz VS, Jacobson RM, Poland GA.

Vaccine. 2011 Oct 19;29(45):7883-95. doi: 10.1016/j.vaccine.2011.08.083. Epub 2011 Aug 27.

8.

Replication of associations between cytokine and cytokine receptor single nucleotide polymorphisms and measles-specific adaptive immunophenotypic extremes.

White SJ, Haralambieva IH, Ovsyannikova IG, Vierkant RA, O'Byrne MM, Poland GA.

Hum Immunol. 2012 Jun;73(6):636-40. doi: 10.1016/j.humimm.2012.03.015. Epub 2012 Apr 12.

9.

HLA class II alleles and measles virus-specific cytokine immune response following two doses of measles vaccine.

Ovsyannikova IG, Jacobson RM, Ryan JE, Vierkant RA, Pankratz VS, Jacobsen SJ, Poland GA.

Immunogenetics. 2005 Feb;56(11):798-807. Epub 2005 Jan 27.

PMID:
15712014
10.

Single-nucleotide polymorphism associations in common with immune responses to measles and rubella vaccines.

Ovsyannikova IG, Salk HM, Larrabee BR, Pankratz VS, Poland GA.

Immunogenetics. 2014 Nov;66(11):663-9. doi: 10.1007/s00251-014-0796-z. Epub 2014 Aug 21.

PMID:
25139337
11.

Correlations between vaccinia-specific immune responses within a cohort of armed forces members.

Umlauf BJ, Ovsyannikova IG, Haralambieva IH, Kennedy RB, Vierkant RA, Pankratz VS, Jacobson RM, Poland GA.

Viral Immunol. 2011 Oct;24(5):415-20. doi: 10.1089/vim.2011.0029. Epub 2011 Sep 29.

12.

The role of polymorphisms in Toll-like receptors and their associated intracellular signaling genes in measles vaccine immunity.

Ovsyannikova IG, Haralambieva IH, Vierkant RA, Pankratz VS, Jacobson RM, Poland GA.

Hum Genet. 2011 Oct;130(4):547-61. doi: 10.1007/s00439-011-0977-x. Epub 2011 Mar 19.

13.

Immunologic significance of HLA class I genes in measles virus-specific IFN-gamma and IL-4 cytokine immune responses.

Ovsyannikova IG, Ryan JE, Vierkant RA, Pankratz VS, Jacobson RM, Poland GA.

Immunogenetics. 2005 Dec;57(11):828-36. Epub 2005 Dec 6.

PMID:
16331510
14.

Associations between measles vaccine immunity and single-nucleotide polymorphisms in cytokine and cytokine receptor genes.

Dhiman N, Ovsyannikova IG, Cunningham JM, Vierkant RA, Kennedy RB, Pankratz VS, Poland GA, Jacobson RM.

J Infect Dis. 2007 Jan 1;195(1):21-9. Epub 2006 Nov 20.

15.

Interleukin-4 induced by measles virus and measles-derived peptides as measured by IL-4 receptor-blocking ELISA.

Dhiman N, Ovsyannikova IG, Howe RC, Ryan JE, Jacobson RM, Poland GA.

J Immunol Methods. 2004 Apr;287(1-2):217-25.

PMID:
15099769
16.

Genetic polymorphisms in host antiviral genes: associations with humoral and cellular immunity to measles vaccine.

Haralambieva IH, Ovsyannikova IG, Umlauf BJ, Vierkant RA, Shane Pankratz V, Jacobson RM, Poland GA.

Vaccine. 2011 Nov 8;29(48):8988-97. doi: 10.1016/j.vaccine.2011.09.043. Epub 2011 Sep 20.

17.

Evaluation of live trivalent vaccine of measles AIK-C strain, mumps Hoshino strain and rubella Takahashi strain, by virus-specific interferon-gamma production and antibody response.

Nakayama T, Urano T, Osano M, Nakagawa M, Maehara N, Sasaki K, Yamamura AM, Makino S.

Microbiol Immunol. 1990;34(6):497-508.

PMID:
2120551
18.

Correlates of lymphoproliferative responses to measles, mumps, and rubella (MMR) virus vaccines following MMR-II vaccination in healthy children.

Dhiman N, Ovsyannikova IG, Jacobson RM, Vierkant RA, Pankratz VS, Jacobsen SJ, Poland GA.

Clin Immunol. 2005 May;115(2):154-61.

PMID:
15885638
19.

Induction of cytokine mRNA in peripheral blood mononuclear cells of infants after the first dose of measles vaccine.

Li H, Hickman CJ, Helfand RF, Keyserling H, Anderson LJ, Bellini WJ.

Vaccine. 2001 Sep 14;19(32):4896-900.

PMID:
11535343
20.

TLR3 and RIG-I gene variants: associations with functional effects on receptor expression and responses to measles virus and vaccine in vaccinated infants.

Clifford HD, Yerkovich ST, Khoo SK, Zhang G, Upham J, Le Souëf PN, Richmond P, Hayden CM.

Hum Immunol. 2012 Jun;73(6):677-85. doi: 10.1016/j.humimm.2012.03.004. Epub 2012 Apr 12.

PMID:
22504413
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk